Ironwood Pharmaceuticals, Inc.(IRWD)- NASDAQ
  • wilkinson99 | Send Message 15 Jul

    Top % Gainers: $CIDM 36%, $SGRP 30%, $HLF 18%, $ARDX 12%, $OPTT 12%, $ITI 12%, $VNR 9%, $MGT 9%, $ALR 8% $RADA $IRWD $NTDOY $MEET $ARTH $STV
      • StockConsultant | Send Message 11 Jul

        Notable breakout watch stocks $AKAM $BITA $CALD $DPLO $EA $ENLK $IRWD $JWN $RPTP analysis at
          • freefdawatchlist | Send Message 8 May

   After hour earnings for May 9th: $HALO, $HTZ, $INVN, $IRWD, $OAS, $OPK, $PAH, $RAX, $SCTY, $STMP, $SEDG
              • Phase Five Research | Send Message 27 Apr

                Uncovered: Safety Issues Linked With Ironwood's Drug, Linzess $IRWD
                  • freefdawatchlist | Send Message 27 Apr

           Most Volatile stocks: $ORIG, $SEED, $UNXL, $BCRX, $IRWD
                      • hikeleader | Send Message 26 Apr

                        $SGYP - Tough report out on $IRWD Linzess:
                        Reply (1)
                        • Vina1234 | Send Message 27 Apr
                          : $SGYP It was tough and damning Report for $IRWD
                          • freefdawatchlist | Send Message 18 Feb

                   After Hour Earnings: $RGLS, $CENX, $JWN, $IRWD, $AHS, $LHO
                              • freefdawatchlist | Send Message 18 Feb

                       Earning Play for Feb 18th: $MPEL, $WAB, $VA, $EIGI, $CAB, $DNR, $AGIO, $RGLS, $CENX, $JWN, $IRWD
                                  • timtrading | Send Message 17 Sep 2015

                                    bullish engulfing patterns $HYG,$DRI,$MFA,$OVAS,$IRWD,$AEGR,$ZSPH,$HQY,$SRNE,$TIP
                                      • wazzaofwallst | Send Message 23 Jun 2015

                                        Exciting growth expectations for Ironwood Pharmaceuticals - $IRWD -
                                          Company Description
                                          Ironwood Pharmaceuticals, Inc. is an pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient's lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with... More
                                          Sector: Healthcare
                                          Industry: Medical Laboratories & Research
                                          Country: United States